Literature DB >> 10762564

A pneumococcal protein that elicits interleukin-8 from pulmonary epithelial cells.

M Madsen1, Y Lebenthal, Q Cheng, B L Smith, M K Hostetter.   

Abstract

To understand how neutrophils are recruited to the lung in pneumococcal pneumonia, the ability of pneumococcal components to elicit the chemokine interleukin (IL)-8 from monolayers of cultured human type II cells was assessed. Heat-killed clinical and laboratory strains of Streptococcus pneumoniae and secreted proteins from exponentially growing pneumococci elicited significant quantities of IL-8 from A549 cells. All strains that elicited IL-8 production secreted a protein ( approximately 90 kDa) that comigrated on SDS-PAGE with a C3-binding protein previously identified in S. pneumoniae. As little as 7 pmol of the purified 90-kDa protein readily elicited levels of IL-8 production equivalent to those obtained with 1 U of IL-1alpha. Supernatant proteins and heat-killed cells of an isogenic mutant that failed to produce the C3-binding protein elicited significantly less IL-8 than did supernatant proteins or heat-killed cells of the parent strain. These results implicate the C3-binding protein of S. pneumoniae in a novel pathway of pulmonary inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762564     DOI: 10.1086/315388

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces.

Authors:  Adam J Ratner; Elena S Lysenko; Marina N Paul; Jeffrey N Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

2.  Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.

Authors:  Priya Balachandran; Alexis Brooks-Walter; Anni Virolainen-Julkunen; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 3.  Advances in pneumococcal vaccines: advantages for infants and children.

Authors:  Jolanta Bernatoniene; Adam Finn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Cigarette smoke inhibits airway epithelial cell innate immune responses to bacteria.

Authors:  Ritwij Kulkarni; Ryan Rampersaud; Jorge L Aguilar; Tara M Randis; James L Kreindler; Adam J Ratner
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

5.  Differential role of CbpA and PspA in modulation of in vitro CXC chemokine responses of respiratory epithelial cells to infection with Streptococcus pneumoniae.

Authors:  Rikki M A Graham; James C Paton
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

6.  Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.

Authors:  Y Zhang; A W Masi; V Barniak; K Mountzouros; M K Hostetter; B A Green
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.

Authors:  Qibo Zhang; Sharon Choo; Adam Finn
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract.

Authors:  C E Blue; G K Paterson; A R Kerr; M Bergé; J P Claverys; T J Mitchell
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide.

Authors:  Tamika Burns; Zhaojing Zhong; Michael Steinitz; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Differential activation of inflammatory pathways in A549 type II pneumocytes by Streptococcus pneumoniae strains with different adherence properties.

Authors:  Rachel L Robson; Natalie A Reed; Rebecca T Horvat
Journal:  BMC Infect Dis       Date:  2006-04-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.